Below are our most recent news releases. Click on a news item to read more.
May 19, 2021 – MAIA Biotechnology, Inc. Raises $8.0 Million Financing to Advance Pipeline of Targeted Immuno-Oncology Studies
Mar 25, 2021 – MAIA Biotechnology to Present at Upcoming Investor Conferences
Feb 2, 2021 – MAIA Biotechnology, Inc. Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating THIO in Sequential Administration with Libtayo® (cemiplimab) in Advanced Non-Small Cell Lung Cancer
Jul 07, 2020 – MAIA Biotechnology, Inc. Announces Publication in Cancer Cell of Encouraging Data on the Immunogenic Effects of Its Flagship Product Candidate THIO
Currently, there are no future events scheduled for MAIA. Please check back soon.
Mar 29-Apr 2, 2021 – MedInvest Spring 2021 Oncology Investor Conference
Mar 23-25, 2021 – Keiretsu Midwest Angel Forum